Unicycive Therapeutics, Inc. (UNCY) vs VAXART, INC. (VXRT)

Unicycive Therapeutics, Inc. and VAXART, INC. are both Biotechnology companies. Unicycive Therapeutics, Inc. and VAXART, INC. are of similar size ($96.9M and $92.4M). Unicycive Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. has the higher net margin (16.0% vs 0.00%) and the higher return on invested capital (2,542.3% vs 0.00%). Across the 13 metrics below, VAXART, INC. leads on 12 and Unicycive Therapeutics, Inc. on 1.

Valuation

Metric UNCY VXRT Biotechnology median
P/E n/m 2.85 10.60
P/S n/m 0.50 9.40
P/B 1.78 1.36 2.13
Price to free cash flow n/m 2.81 25.18
EV/EBITDA n/m 0.56 0.66
EV/Sales n/m 0.14 9.02
Earnings yield (45.67%) 35.14% (32.88%)
Free cash flow yield (29.31%) 35.55% (23.13%)

Profitability

Metric UNCY VXRT Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 16.63% 0.00%
Net margin 0.00% 16.02% 0.00%
Free cash flow margin 0.00% 17.64% 0.00%
Return on equity (101.07%) 62.42% (51.96%)
Return on assets (69.05%) 16.26% (46.06%)
Return on invested capital 0.00% 2,542.26% 0.00%

Growth

Metric UNCY VXRT Biotechnology median
Revenue growth (TTM) — 22.31% 6.76%
EPS growth (last fiscal year) 70.18% 121.21% 29.88%
Revenue growth, 5-year CAGR — 125.76% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric UNCY VXRT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.81 1.71 4.97
Net debt to EBITDA 1.43 (2.42) 1.01

Dividend

Metric UNCY VXRT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric UNCY VXRT Biotechnology median
Market cap 96.94m 92.41m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack